drugset / Trial / NCT01471808
Effects of Different Early Intensive Therapies on Long-term β-cell Function
Phase 4
Completed
264 enrolled
Sun Yat-sen University
First People's Hospital of Foshan · collabNanfang Hospital, Southern Medical University · collabPeking University Shenzhen Hospital · collabSun Yat-Sen Memorial Hospital of Sun Yat-Sen University · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate and evaluate the effects of different oral antihyperglycaemic agents combined with short-term continuous subcutaneous insulin infusion(CSII)(1.CSII alone; 2.metformin and pioglitazone combined with CSII; 3. sitagliptin combined with CSII) on long-term glycemic control and β-cell function in newly diagnosed type 2 diabetic patients.
Timeline
- Start
- 2011-10
- Primary completion
- 2018-12
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metformin | Small molecule | 1.5 g | Oral |
| Comparator | Pioglitazone | Small molecule | 30 mg | Oral |
| Comparator | Sitagliptin | Small molecule | 100 mg | Oral |